| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 3.478 | 10.162 | 26.409 | 54.369 | 31.517 | 25.585 |
| Total Income - EUR | - | - | - | 0 | 3.478 | 10.162 | 26.409 | 54.369 | 31.517 | 25.585 |
| Total Expenses - EUR | - | - | - | 55 | 4.875 | 9.943 | 25.567 | 51.394 | 30.184 | 24.673 |
| Gross Profit/Loss - EUR | - | - | - | -55 | -1.397 | 219 | 842 | 2.975 | 1.333 | 911 |
| Net Profit/Loss - EUR | - | - | - | -55 | -1.501 | -65 | 50 | 1.419 | 1.131 | 774 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Casa Bioverdena S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 52 | 1.848 | 4.620 | 11.008 | 20.496 | 23.590 | 36.448 |
| Inventories | - | - | - | 0 | 1.519 | 3.590 | 10.358 | 18.488 | 21.013 | 34.373 |
| Receivables | - | - | - | 0 | 51 | 102 | 536 | 885 | 1.647 | 1.837 |
| Cash | - | - | - | 52 | 279 | 928 | 114 | 1.123 | 929 | 239 |
| Shareholders Funds | - | - | - | -12 | -1.513 | -1.549 | -1.465 | -50 | 1.081 | 1.849 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 64 | 3.362 | 6.170 | 12.473 | 20.546 | 22.509 | 34.600 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4532 - 4532" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Casa Bioverdena S.r.l.